3157 related articles for article (PubMed ID: 19664631)
21. A comparative study on Helicobacter pylori infection in peptic ulcer disease patients with or without previous eradication therapy.
Chen LW; Chien RN; Fang KM; Yen CL; Chang JJ; Lee TS; Liu CJ; Chang LC
Hepatogastroenterology; 2007 Dec; 54(80):2209-11. PubMed ID: 18265634
[TBL] [Abstract][Full Text] [Related]
22. Helicobacter pylori eradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogen II levels in patients with duodenal ulcer.
Pimanov SI; Makarenko EV; Voropaeva AV; Matveenko ME; Voropaev EV
J Gastroenterol Hepatol; 2008 Nov; 23(11):1666-71. PubMed ID: 17559360
[TBL] [Abstract][Full Text] [Related]
23. Helicobacter pylori and peptic ulcer disease. Current evidence for management strategies.
Chiba N; Lahaie R; Fedorak RN; Bailey R; Veldhuyzen van Zanten SJ; Bernucci B
Can Fam Physician; 1998 Jul; 44():1481-8. PubMed ID: 9678277
[TBL] [Abstract][Full Text] [Related]
24. Design and planned analyses of an ongoing randomized trial assessing the preventive effect of Helicobacter pylori eradication on occurrence of new gastric carcinomas after endoscopic resection.
Kikuchi S; Kato M; Katsuyama T; Tominaga S; Asaka M
Helicobacter; 2006 Jun; 11(3):147-51. PubMed ID: 16684261
[TBL] [Abstract][Full Text] [Related]
25. Eradication of Helicobacter pylori for the prevention of peptic ulcer rebleeding.
Gisbert JP; Calvet X; Feu F; Bory F; Cosme A; Almela P; Santolaria S; Aznárez R; Castro M; Fernández N; García-Grávalos R; Cañete N; Benages A; Montoro M; Borda F; Pérez-Aisa A; Piqué JM
Helicobacter; 2007 Aug; 12(4):279-86. PubMed ID: 17669099
[TBL] [Abstract][Full Text] [Related]
26. Maintenance therapy with H2-receptor antagonist until assessment of Helicobacter pylori eradication can reduce recurrence of peptic ulcer after successful eradication of the organism: prospective randomized controlled trial.
Murakami K; Sato R; Okimoto T; Watanabe K; Nasu M; Kodama M; Fujioka T
J Gastroenterol Hepatol; 2006 Jun; 21(6):1048-53. PubMed ID: 16724993
[TBL] [Abstract][Full Text] [Related]
27. Helicobacter pylori eradication and gastric cancer: when is the horse out of the barn?
de Vries AC; Kuipers EJ; Rauws EA
Am J Gastroenterol; 2009 Jun; 104(6):1342-5. PubMed ID: 19491846
[TBL] [Abstract][Full Text] [Related]
28. Interaction of nonsteroidal anti-inflammatory drugs (NSAID) with Helicobacter pylori in the stomach of humans and experimental animals.
Brzozowski T; Konturek PC; Sliwowski Z; Kwiecień S; Drozdowicz D; Pawlik M; Mach K; Konturek SJ; Pawlik WW
J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():67-79. PubMed ID: 17033106
[TBL] [Abstract][Full Text] [Related]
29. Helicobacter pylori eradication in the healing of atrophic gastritis: a one-year prospective study.
Arkkila PE; Seppälä K; Färkkilä MA; Veijola L; Sipponen P
Scand J Gastroenterol; 2006 Jul; 41(7):782-90. PubMed ID: 16785190
[TBL] [Abstract][Full Text] [Related]
30. Clinical features of gastric cancer discovered after successful eradication of Helicobacter pylori: results from a 9-year prospective follow-up study in Japan.
Kamada T; Hata J; Sugiu K; Kusunoki H; Ito M; Tanaka S; Inoue K; Kawamura Y; Chayama K; Haruma K
Aliment Pharmacol Ther; 2005 May; 21(9):1121-6. PubMed ID: 15854174
[TBL] [Abstract][Full Text] [Related]
31. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
Lai KC; Chu KM; Hui WM; Wong BC; Hu WH; Wong WM; Chan AO; Wong J; Lam SK
Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912
[TBL] [Abstract][Full Text] [Related]
32. Helicobacter pylori: beyond peptic ulcer disease.
Wisniewski RM; Peura DA
Gastroenterologist; 1997 Dec; 5(4):295-305. PubMed ID: 9436005
[TBL] [Abstract][Full Text] [Related]
33. The prevalence of peptic ulcer not related to Helicobacter pylori or non-steroidal anti-inflammatory drug use is negligible in southern Europe.
Arroyo MT; Forne M; de Argila CM; Feu F; Arenas J; de la Vega J; Garrigues V; Mora F; Castro M; Bujanda L; Cosme A; Castiella A; Gisbert JP; Hervas A; Lanas A
Helicobacter; 2004 Jun; 9(3):249-54. PubMed ID: 15165261
[TBL] [Abstract][Full Text] [Related]
34. Meta-analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users.
Vergara M; Catalán M; Gisbert JP; Calvet X
Aliment Pharmacol Ther; 2005 Jun; 21(12):1411-8. PubMed ID: 15948807
[TBL] [Abstract][Full Text] [Related]
35. Helicobacter pylori infection does not affect the early rebleeding rate in patients with peptic ulcer bleeding after successful endoscopic hemostasis: a prospective single-center trial.
Schilling D; Demel A; Nüsse T; Weidmann E; Riemann JF
Endoscopy; 2003 May; 35(5):393-6. PubMed ID: 12701009
[TBL] [Abstract][Full Text] [Related]
36. Treatment of Helicobacter pylori infections.
Thijs JC; Kuipers EJ; van Zwet AA; Pena AS; de Graaff J
QJM; 1995 Jun; 88(6):369-89. PubMed ID: 7648229
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of Helicobacter pylori eradication therapy in chronic liver disease.
Jung SW; Lee SW; Hyun JJ; Kim DI; Koo JS; Yim HJ; Park JJ; Lee HS; Chun HJ; Um SH; Choi JH; Kim CD; Ryu HS
Dig Liver Dis; 2009 Feb; 41(2):134-40. PubMed ID: 18436489
[TBL] [Abstract][Full Text] [Related]
38. Size of the peptic ulcer in Helicobacter pylori-positive patients: association with the clinical and histological characteristics.
Arkkila PE; Kokkola A; Seppälä K; Sipponen P
Scand J Gastroenterol; 2007 Jun; 42(6):695-701. PubMed ID: 17505991
[TBL] [Abstract][Full Text] [Related]
39. Peptic ulcer disease today.
Yuan Y; Padol IT; Hunt RH
Nat Clin Pract Gastroenterol Hepatol; 2006 Feb; 3(2):80-9. PubMed ID: 16456574
[TBL] [Abstract][Full Text] [Related]
40. Effect of Helicobacter pylori eradication on incidence of gastric cancer in human and animal models: underlying biochemical and molecular events.
Kabir S
Helicobacter; 2009 Jun; 14(3):159-71. PubMed ID: 19702845
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
